Centenarian Sequencing Contest Begins

The first company to attempt to cheaply sequence the genomes of 100 people aged over 100 announced its intention to compete for the 2013 X prize.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Ion Torrent, a high-tech sequencing company, announced on Monday (July 23) that it will try to sequence 100 genomes of centenarians for $1,000 each, in 30 days, making it the first company to enter next year’s X Prize competition, which promises $10 million to the winning team.

There is still plenty of time for other contestants to throw their hats in. The contest doesn’t begin until September 2013, and entries are permitted up until next May. The criteria for winning, however, are quite stiff, requiring that contestants sequence genomes at less than $1,000 a pop, with at least 98 percent completion and less than one error per million base pairs, reported Nature. As the contestants look for gene variants that could be involved in longevity, they also must be able to report which variants came from which chromosomal.

Since several “next-next gen” sequencing companies, or companies that have developed new ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Edyta Zielinska

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

An illustration of different-shaped bacteria.

Leveraging PCR for Rapid Sterility Testing

Conceptual 3D image of DNA on a blue background.

Understanding the Nuts and Bolts of qPCR Assay Controls 

Bio-Rad
Takara Bio

Takara Bio USA Holdings, Inc. announces the acquisition of Curio Bioscience, adding spatial biology to its broad portfolio of single-cell omics solutions